Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Tuberculosis now rivals AIDS as leading cause of death: WHO

For the first time, tuberculosis infections rivaled HIV/AIDS as a leading cause of death from infectious diseases, the World Health Organization said in a report released on Wednesday.   It found that during 2014, 1.1 million people died of TB in 2014. During the same period, HIV/AIDS killed 1.2 million people globally, including 400,000 who […]

Read More »

Videogame maker says study shows its game helps manage ADHD symptoms

Children with ADHD (attention deficit hyperactivity disorder) show signs of improvement after playing a videogame for 30 minutes a day rather than taking a pill, the U.S. company developing the treatment said on Wednesday. Diagnoses for ADHD have risen in recent decades, and some 9.5 percent of children aged 3-17 in the United States had […]

Read More »

Theranos’ Problems Pile Up as the FDA Releases Inspection Notes from Two Lab Visits

Blood-testing startup Theranos Inc., under fire after reports that the company overstated the ability of its tests to accurately perform several dozen types of measurements, has flaws in the process it uses to validate its products, U.S. Food and Drug Administration inspectors found. Heavily redacted inspection reports, posted Tuesday by the FDA, said Theranos’s “design […]

Read More »

U.S. FDA warns Novartis on manufacturing violations at 2 India plants

The U.S. Food and Drug Administration warned Novartis AG last week after the Swiss firm was found in violation of manufacturing practices last year at two of its India drug-making plants, Novartis said.   The warning, issued to Novartis’s generic drugs unit Sandoz on Oct. 22, came after FDA officials inspected its Turbhe and Kalwa […]

Read More »

#FreeBacon topic sizzles on social media after WHO meat report

Bacon lovers took to social media on Tuesday to express disdain over a World Health Organization report that said processed meat is likely to cause cancer.   The hashtags #FreeBacon, #Bacongeddon and #JeSuisBacon were among the top-trending topics worldwide on Twitter for a second straight day. Celebrities, politicians and ordinary consumers were reacting to Monday’s […]

Read More »

Gilead hepatitis C drug sales trend flattens, shares dip

Gilead Sciences Inc on Tuesday said its quarterly profit rose 70 percent, but sales growth for its hepatitis C drugs flattened as health insurers limited access to the expensive treatments. Shares of the biotechnology company fell slightly. Gilead’s quarterly product sales rose 37 percent to $8.2 billion. Sales of hepatitis C drugs Sovaldi and Harvoni […]

Read More »

Macrocure’s cell therapy for wounds fails late study

Israeli biotechnology company Macrocure Ltd said it would “analyze all strategic options” after its cell therapy for hard-to-treat wounds failed a late-stage U.S. study, pushing its shares down more than 50 percent after the bell. Macrocure’s CureXcell, already in use in Israel, is a formulation of living human white blood cells activated to stimulate the […]

Read More »

FDA approves Amgen’s injected immunotherapy for melanoma

U.S. health regulators on Tuesday approved Amgen Inc’s novel cancer immunotherapy for injection into melanoma lesions and lymph nodes of patients with the deadliest form of skin cancer that returns after initial surgery. The drug, to be sold under the brand name Imlygic, is an engineered version of a herpes virus that kills cancer cells […]

Read More »

Arena Pharmaceuticals Announces New Strategic Focus and Cost Reduction Plan

– Strategic priorities include clinical-stage pipeline and core research function –   SAN DIEGO, Oct. 27, 2015 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced plans to improve efficiencies and reduce costs as it focuses on the advancement of its research and development priorities. Arena intends to focus on its key strengths by concentrating […]

Read More »

U.S. deaths drop for leading causes

(Reuters Health) – The U.S. death rate for all causes is continuing to decline, aided by drops in fatalities from leading causes like heart disease, cancer, stroke, diabetes and accidents, new research finds. Between 1969 and 2013, the death rate for all causes declined 43 percent from about 1,279 people for each 100,000 individuals in […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom